Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease

References

• Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management, and Prevention of COPD. Bethesda (MD): GOLD2017 Available from: http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/Accessed December 14, 2017
   Google Scholar
• KimVRogersTJCrinerGJNew concepts in the pathobiology of chronic obstructive pulmonary diseaseProc Am Thorac Soc20085447848518453359
   PubMedGoogle Scholar
• SahaSBrightlingCEEosinophilic airway inflammation in COPDInt J Chron Obstruct Pulmon Dis200611394718046901
   PubMedGoogle Scholar
• CukicVLovreVDragisicDUstamujicAAsthma and chronic obstructive pulmonary disease (COPD): differences and similaritiesMater Sociomed201224210010523678316
   PubMedGoogle Scholar
• EltboliOBafadhelMHollinsFCOPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophilsBMC Pulm Med20141411225007795
   PubMed Web of Science ®Google Scholar
• PizzichiniEPizzichiniMMGibsonPSputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitisAm J Respir Crit Care Med19981585 Pt 1151115179817701
   PubMed Web of Science ®Google Scholar
• LeighRPizzichiniMMMorrisMMMaltaisFHargreaveFEPizzichiniEStable COPD: predicting benefit from high-dose inhaled corticosteroid treatmentEur Respir J200627596497116446316
   PubMed Web of Science ®Google Scholar
• SinghDKolsumUBrightlingCELocantoreNAgustiATal-SingerREosinophilic inflammation in COPD: prevalence and clinical characteristicsEur Respir J20144461697170025323230
   PubMed Web of Science ®Google Scholar
• PascoeSLocantoreNDransfieldMTBarnesNCPavordIDBlood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trialsLancet Respir Med20153643544225878028
   PubMed Web of Science ®Google Scholar
• BafadhelMMcKennaSTerrySAcute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkersAm J Respir Crit Care Med2011184666267121680942
   PubMed Web of Science ®Google Scholar
• JacobsenEAHelmersRALeeJJLeeNAThe expanding role(s) of eosinophils in health and diseaseBlood2012120193882389022936660
   PubMed Web of Science ®Google Scholar
• GeorgeLBrightlingCEEosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary diseaseTher Adv Chronic Dis201671345126770668
   PubMed Web of Science ®Google Scholar
• HoganSPRosenbergHFMoqbelREosinophils: biological properties and role in health and diseaseClin Exp Allergy200838570975018384431
   PubMed Web of Science ®Google Scholar
• DavoineFLacyPEosinophil cytokines, chemokines, and growth factors: emerging roles in immunityFront Immunol2014557025426119
   PubMed Web of Science ®Google Scholar
• LuijkBLindemansCAKantersDGradual increase in priming of human eosinophils during extravasation from peripheral blood to the airways in response to allergen challengeJ Allergy Clin Immunol20051155997100315867857
   PubMed Web of Science ®Google Scholar
• MolfinoNAGossageDKolbeckRParkerJMGebaGPMolecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptorClin Exp Allergy201242571273722092535
   PubMed Web of Science ®Google Scholar
• ConroyDMWilliamsTJEotaxin and the attraction of eosinophils to the asthmatic lungRespir Res20012315015611686879
   PubMed Web of Science ®Google Scholar
• SmitJJLukacsNWA closer look at chemokines and their role in asthmatic responsesEur J Pharmacol20065331–327728816464446
   PubMed Web of Science ®Google Scholar
• MoqbelRLevi-SchafferFKayABCytokine generation by eosinophilsJ Allergy Clin Immunol1994946 Pt 2118311887798558
   PubMed Web of Science ®Google Scholar
• KitaHThe eosinophil: a cytokine-producing cell?J Allergy Clin Immunol19969748898928655882
   PubMed Web of Science ®Google Scholar
• ZieglerSFRoanFBellBDStoklasekTAKitajimaMHanHThe biology of thymic stromal lymphopoietin (TSLP)Adv Pharmacol20136612915523433457
   PubMedGoogle Scholar
• RedhuNSGounniASFunction and mechanisms of TSLP/TSLPR complex in asthma and COPDClin Exp Allergy2012427994100522168549
   PubMed Web of Science ®Google Scholar
• RutgersSRTimensWKaufmannHFvan der MarkTWKoëterGHPostmaDSComparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPDEur Respir J200015110911510678630
   PubMed Web of Science ®Google Scholar
• MeyerKCRaghuGBaughmanRPAn official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung diseaseAm J Respir Crit Care Med201218591004101422550210
   PubMed Web of Science ®Google Scholar
• BrightlingCEBraddingPSymonFAHolgateSTWardlawAJPavordIDMast-cell infiltration of airway smooth muscle in asthmaN Engl J Med2002346221699170512037149
   PubMed Web of Science ®Google Scholar
• GrootendorstDCSontJKWillemsLNComparison of inflammatory cell counts in asthma: induced sputum vs bronchoalveolar lavage and bronchial biopsiesClin Exp Allergy19972777697799249269
   PubMed Web of Science ®Google Scholar
• DuhSHCookJDLaboratory reference range values2005 Available from: www.stedmansonline.com/webFiles/Dict-Stedmans28/APP17.pdfAccessed December 6, 2017
   Google Scholar
• Medical Council of CanadaClinical laboratory tests – normal values Available from: http://mcc.ca/objectives/normal-valuesAccessed December 6, 2017
   Google Scholar
• Medline PlusBlood differential test Available from: https://medline-plus.gov/ency/article/003657.htmAccessed December 6, 2017
   Google Scholar
• WinkelPStatlandBESaundersAMOsbornHKuppermanHWithin-day physiologic variation of leukocyte types in healthy subjects as assayed by two automated leukocyte differential analyzersAm J Clin Pathol19817556937007234755
   PubMed Web of Science ®Google Scholar
• ZacharskiLRElvebackLRKinmanJWLeukocyte counts in healthy adultsAm J Clin Pathol19715621481505567719
   PubMed Web of Science ®Google Scholar
• YoungBLoweJOStevensAHeathJWWheater’s Functional Histology6th edPhiladelphiaChurchill Livingstone2014
   Google Scholar
• Vedel-KroghSNielsenSFLangePVestboJNordestgaardBGBlood eosinophils and exacerbations in chronic obstructive pulmonary disease: the Copenhagen general population studyAm J Respir Crit Care Med2016193996597426641631
   PubMed Web of Science ®Google Scholar
• ChisaleMRKumwendaPNgwiraMM’BayaBChosamataBIMwapasaVA pilot study to determine the normal haematological indices for young Malawian adults in Blantyre, MalawiMalawi Med J20152739610026715954
   PubMed Web of Science ®Google Scholar
• WangBYanLYaoZRoskosLKPopulation pharmacokinetics and pharmacodynamics of benralizumab in healthy volunteers and patients with asthmaCPT Pharmacometrics Syst Pharmacol20176424925728109128
   PubMedGoogle Scholar
• BalbiBPignattiPCorradiMBronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adultsEur Respir J200730476978117906085
   PubMed Web of Science ®Google Scholar
• DavidsonWJTheSLeighREstablishing a normal range for induced sputum cell counts in western CanadaCan Respir J201320642442524083301
   PubMed Web of Science ®Google Scholar
• NegewoNAMcDonaldVMBainesKJPeripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPDInt J Chron Obstruct Pulmon Dis2016111495150427445469
   PubMed Web of Science ®Google Scholar
• KreindlerJLWatkinsMLLettisSTal-SingerRLocantoreNEffect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPDBMJ Open Respir Res201631e000151
   PubMed Web of Science ®Google Scholar
• BrightlingCEMonteiroWWardRSputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trialLancet200035692401480148511081531
   PubMed Web of Science ®Google Scholar
• RoyKSmithJKolsumUBorrillZVestboJSinghDCOPD phenotype description using principal components analysisRespir Res2009104119480658
   PubMed Web of Science ®Google Scholar
• BafadhelMMcKennaSTerrySBlood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trialAm J Respir Crit Care Med20121861485522447964
   PubMed Web of Science ®Google Scholar
• LacosteJYBousquetJChanezPEosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary diseaseJ Allergy Clin Immunol19939245375488409114
   PubMed Web of Science ®Google Scholar
• AminiMBashirovaDPrinsBPEosinophil count is a common factor for complex metabolic and pulmonary traits and diseases: the LifeLines Cohort StudyPLoS One20161112e016848027978545
   PubMed Web of Science ®Google Scholar
• SennelsHPJørgensenHLHansenALGoetzeJPFahrenkrugJDiurnal variation of hematology parameters in healthy young males: the Bispebjerg study of diurnal variationsScand J Clin Lab Invest201171753254121988588
   PubMed Web of Science ®Google Scholar
• SpectorSLTanRAIs a single blood eosinophil count a reliable marker for “eosinophilic asthma”?J Asthma201249880781022900679
   PubMed Web of Science ®Google Scholar
• BasantaMIbrahimBDockryRExhaled volatile organic compounds for phenotyping chronic obstructive pulmonary disease: a cross-sectional studyRespir Res2012137222916684
   PubMed Web of Science ®Google Scholar
• BrightlingCEMcKennaSHargadonBSputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary diseaseThorax200560319319815741434
   PubMed Web of Science ®Google Scholar
• PavordIDLettisSLocantoreNBlood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPDThorax201671211812526585525
   PubMed Web of Science ®Google Scholar
• PavordIDLettisSAnzuetoABarnesNBlood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysisLancet Respir Med20164973174127460163
   PubMed Web of Science ®Google Scholar
• OrtegaHKatzLGunsoyNKeeneOYanceySBlood eosinophil counts predict treatment response in patients with severe eosinophilic asthmaJ Allergy Clin Immunol2015136382582626194540
   PubMed Web of Science ®Google Scholar
• SchleichFBrusselleGLouisRHeterogeneity of phenotypes in severe asthmatics: the Belgian Severe Asthma Registry (BSAR)Respir Med2014108121723173225456708
   PubMed Web of Science ®Google Scholar
• WatzHTetzlaffKWoutersEFBlood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trialLancet Respir Med20164539039827066739
   PubMed Web of Science ®Google Scholar
• BrightlingCEBleeckerERPanettieriRABenralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2A studyLancet Respir Med201421189190125208464
   PubMed Web of Science ®Google Scholar
• SiddiquiSHGuasconiAVestboJBlood eosinophils: a biomarker of response to extrafine beclomethasone/formoterol in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2015192452352526051430
   PubMed Web of Science ®Google Scholar
• WedzichaJABanerjiDChapmanKRIndacaterol-glycopyrronium versus salmeterol-fluticasone for COPDN Engl J Med2016374232222223427181606
   PubMed Web of Science ®Google Scholar
• BarnesNSharmaRLettisSCalvarleyPBlood eosinophils as a marker of response to inhaled corticosteroids in COPDEur Respir J2016471299130327132257
   PubMed Web of Science ®Google Scholar
• de GrootJCStormHAmelinkMClinical profile of patients with adult-onset eosinophilic asthmaERJ Open Res20162200100201527730197
   PubMedGoogle Scholar
• EltboliOMistryVBarkerBBrightlingCERelationship between blood and bronchial submucosal eosinophilia and reticular basement membrane thickening in chronic obstructive pulmonary diseaseRespirology201520466767025645275
   PubMed Web of Science ®Google Scholar
• HastieAAlexisNDoerschuckCBlood eosinophils poorly correlate with sputum eosinophils, and have few associations with spirometry, clinical and quantitated computed tomography measures compared to sputum eosinophils in the SPIROMICS cohortAm J Respir Crit Care Med2016139Suppl Available from:http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2016.193.1_MeetingAbstracts.A6168Accessed December 12, 2017
   Google Scholar
• KolsumUDameraGPhamTHPulmonary inflammation in patients with chronic obstructive pulmonary disease with higher blood eosinophil countsJ Allergy Clin Immunol201714041181.e71184.e728506852
   PubMed Web of Science ®Google Scholar
• TuratoGSemenzatoUBazzanEBlood eosinophilia does not reflect tissue eosinophils nor worsen clinical outcomes in COPDAm J Respir Crit Care Med Epub20171016
   Google Scholar
• RavinKALoyMThe eosinophil in infectionClin Rev Allergy Immunol201650221422726690368
   PubMed Web of Science ®Google Scholar
• OshagbemiOABurdenAMBraekenDCWStability of blood eosinophils in patients with chronic obstructive pulmonary disease and in control subjects, and the impact of sex, age, smoking, and baseline countsAm J Respir Crit Care Med2017195101402140428165763
   PubMed Web of Science ®Google Scholar
• MoermansCBonnetCWillemsESputum cytokine levels in patients undergoing hematopoietic SCT and comparison with healthy subjects and COPD: a pilot studyBone Marrow Transplant201449111382138825068427
   PubMed Web of Science ®Google Scholar
• BalzanoGStefanelliFIorioCEosinophilic inflammation in stable chronic obstructive pulmonary disease: relationship with neutrophils and airway functionAm J Respir Crit Care Med19991605 Pt 11486149210556110
   PubMed Web of Science ®Google Scholar
• MoermansCHeinenVNguyenMLocal and systemic cellular inflammation and cytokine release in chronic obstructive pulmonary diseaseCytokine201156229830421880505
   PubMed Web of Science ®Google Scholar
• KimVLCoombsNAStaplesKJImpact and associations of eosinophilic inflammation in COPD: analysis of the AERIS cohortEur Respir J2017504
   Web of Science ®Google Scholar
• University of North CarolinaStudy of COPD subgroups and biomarkers (SPIROMICS) Available from: https://clinicaltrials.gov/ct2/show/NCT1969344. NLM identifier: NCT1969344Accessed December 12, 2017
   Google Scholar
• MartinezCHLiSXHirzelAJAlveolar eosinophilia in current smokers with chronic obstructive pulmonary disease in the SPIROMICS cohortJ Allergy Clin Immunol Epub2017912
   Google Scholar
• Brigham and Women’s HospitalExamining the genetic factors that may cause chronic obstructive pulmonary disease (COPD) (COPDGene) Available from: https://clinicaltrials.gov/ct2/show/NCT0608764. NLM identifier: NCT0608764Accessed December 12, 2017
   Google Scholar
• AstraZenecaObservational study of obstructive lung disease (NOVELTY) Available from: https://clinicaltrials.gov/ct2/show/NCT2760329. NLM identifier: NCT2760329Accessed December 12, 2017
   Google Scholar
• PriceDRigazioAPostmaDBlood eosinophilia and the number of exacerbations in COPD patientsEur Respir J201444Suppl 584416
   Google Scholar
• PapiABellettatoCMBraccioniFInfections and airway inflammation in chronic obstructive pulmonary disease severe exacerbationsAm J Respir Crit Care Med2006173101114112116484677
   PubMed Web of Science ®Google Scholar
• FujimotoKYasuoMUrushibataKHanaokaMKoizumiTKuboKAirway inflammation during stable and acutely exacerbated chronic obstructive pulmonary diseaseEur Respir J200525464064615802337
   PubMed Web of Science ®Google Scholar
• PrinsHJDuijkersRLutterRBlood eosinophilia as a marker of early and late treatment failure in severe acute exacerbations of COPDRespir Med201713111812428947018
   PubMed Web of Science ®Google Scholar
• ChengSLLinCHEffectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic countsInt J Chron Obstruct Pulmon Dis2016112341234827703344
   PubMed Web of Science ®Google Scholar
• SivaRGreenRHBrightlingCEEosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trialEur Respir J200729590691317301099
   PubMed Web of Science ®Google Scholar
• KolsumUDonaldsonGCSinghRBlood and sputum eosinophils in COPD: relationship with bacterial loadRespir Res20171818828482840
   PubMed Web of Science ®Google Scholar
• ContoliMPaulettiARossiMRLong-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPDEur Respir J2017504170045128982774
   PubMed Web of Science ®Google Scholar
• LamsBESousaARReesPJLeeTHSubepithelial immunopathology of the large airways in smokers with and without chronic obstructive pulmonary diseaseEur Respir J200015351251610759445
   PubMed Web of Science ®Google Scholar
• MillerMRamsdellJFriedmanPJChoJYRenvallMBroideDHComputed tomographic scan-diagnosed chronic obstructive pulmonary disease-emphysema: eotaxin-1 is associated with bronchodilator response and extent of emphysemaJ Allergy Clin Immunol200712051118112517983873
   PubMed Web of Science ®Google Scholar
• D’ArmientoJMScharfSMRothMDEosinophil and T cell markers predict functional decline in COPD patientsRespir Res20091011319925666
   PubMed Web of Science ®Google Scholar
• JansonCLarssonKLisspersKHPneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting β2 agonist: observational matched cohort study (PATHOS)BMJ2013346f330623719639
   PubMed Web of Science ®Google Scholar
• KewKMSeniukovichAInhaled steroids and risk of pneumonia for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20143CD01011524615270
   PubMed Web of Science ®Google Scholar
• MorjariaJBRigbyAMoriceAHInhaled corticosteroid use and the risk of pneumonia and COPD exacerbations in the UPLIFT studyLung2017195328128828255905
   PubMed Web of Science ®Google Scholar
• SinghSLokeYKRisk of pneumonia associated with long-term use of inhaled corticosteroids in chronic obstructive pulmonary disease: a critical review and updateCurr Opin Pulm Med201016211812219926996
   PubMed Web of Science ®Google Scholar
• SuissaSPatenaudeVLapiFErnstPInhaled corticosteroids in COPD and the risk of serious pneumoniaThorax201368111029103624130228
   PubMed Web of Science ®Google Scholar
• WangCYLaiCCYangWCThe association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients’ life quality with COPD in Taiwan (IMPACT) studyInt J Chron Obstruct Pulmon Dis2016112775278327877031
   PubMed Web of Science ®Google Scholar
• HindsDRDiSantostefanoRLLeHVPascoeSIdentification of responders to inhaled corticosteroids in a chronic obstructive pulmonary disease population using cluster analysisBMJ Open201666e010099
   PubMed Web of Science ®Google Scholar
• RocheNChapmanKRVogelmeierCFBlood eosinophils and response to maintenance chronic obstructive pulmonary disease treatment: data from the FLAME trialAm J Respir Crit Care Med201719591189119728278391
   PubMed Web of Science ®Google Scholar
• PostmaDSRabeKFThe asthma-COPD overlap syndromeN Engl J Med2015373131241124926398072
   PubMed Web of Science ®Google Scholar
• LouisRECataldoDBuckleyMGEvidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary diseaseEur Respir J200220232533112212963
   PubMed Web of Science ®Google Scholar
• SoltaniAEweYPLimZSMast cells in COPD airways: relationship to bronchodilator responsiveness and angiogenesisEur Respir J20123961361136722034650
   PubMed Web of Science ®Google Scholar
• SinDDMiravitllesMManninoDMWhat is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussionEur Respir J201648366467327338195
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma (GINA)Global Strategy for Asthma Management and Prevention2017 Available from: http://ginasthma.org/2017-gina-report-global-strategy-for-asthma-management-and-prevention/Accessed December 13, 2017
   Google Scholar
• Soler-CataluñaJJCosíoBIzquierdoJLConsensus document on the overlap phenotype COPD-asthma in COPDArch Bronconeumol201248933133722341911
   PubMed Web of Science ®Google Scholar
• KoblizekVChlumskyJZindrVChronic obstructive pulmonary disease: official diagnosis and treatment guidelines of the Czech Pneu-mological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented careBiomed Pap Med Fac Univ Palacky Olomouc Czech Repub2013157218920123733084
   PubMed Web of Science ®Google Scholar
• CosíoBGSorianoJBLopez-CamposJLDefining the asthma-COPD overlap syndrome in a COPD cohortChest20161491455226291753
   PubMed Web of Science ®Google Scholar
• CosíoBGde LlanoLPViñaALTh-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome?Eur Respir J2017495160239728461299
   PubMed Web of Science ®Google Scholar
• MiravitllesMSoler-CataluñaJJCalleMSpanish guidelines for management of chronic obstructive pulmonary disease (GesEPOC) 2017: pharmacological treatment of stable phaseArch Bronconeumol201753632433528477954
   PubMed Web of Science ®Google Scholar
• WedzichaJACalverleyPMSeemungalTAThe prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromideAm J Respir Crit Care Med20081771192617916806
   PubMed Web of Science ®Google Scholar
• HollisSJorupCLythgoeDMartenssonGRegnellPEckerwallGRisk of pneumonia with budesonide-containing treatments in COPD: an individual patient-level pooled analysis of interventional studiesInt J Chron Obstruct Pulmon Dis2017121071108428435240
   PubMed Web of Science ®Google Scholar
• SinDDTashkinDZhangXBudesonide and the risk of pneumonia: a meta-analysis of individual patient dataLancet2009374969171271919716963
   PubMed Web of Science ®Google Scholar
• GlaxoSmithKlineEfficacy and safety of mepolizumab as an add-on treatment in COPD Available from: https://clinicaltrials.gov/ct2/show/NCT2105961. NLM identifier: NCT2105961Accessed December 14, 2017
   Google Scholar
• GlaxoSmithKlineStudy to evaluate efficacy and safety of mepolizumab for frequently exacerbating COPD patients Available from: https://clinicaltrials.gov/ct2/show/NCT2105948. NLM identifier: NCT2105948Accessed December 14, 2017
   Google Scholar
• AstraZenecaEfficacy and safety of benralizumab in patients with moderate to very severe COPD with exacerbation history (TERRANOVA) Available from: https://clinicaltrials.gov/ct2/show/NCT2155660. NLM identifier: NCT2155660Accessed December 14, 2017
   Google Scholar
• AstraZenecaBenralizumab efficacy in moderate to very severe COPD with exacerbation history (GALATHEA) Available from: https://clinicaltrials.gov/ct2/show/NCT2138916. NLM identifier: NCT2138916Accessed December 14, 2017
   Google Scholar
• Hoffmann-La RocheA study to evaluate safety and efficacy of lebrikizumab in patients with chronic obstructive pulmonary disease Available from: https://clinicaltrials.gov/ct2/show/NCT2546700. NLM identifier: NCT2546700Accessed December 14, 2017
   Google Scholar
• CorrenJWeinsteinSJankaLZangrilliJGarinMPhase 3 study of reslizumab in patients with poorly controlled asthma: effects across a broad range of eosinophil countsChest2016150479981027018175
   PubMed Web of Science ®Google Scholar
• DasguptaAKjarsgaardMCapaldiDA pilot randomised clinical trial of mepolizumab in COPD with eosinophilic bronchitisEur Respir J2017493160248628298405
   PubMed Web of Science ®Google Scholar
• GlaxoSmithKlineGSK announces headline phase III results of mepolizumab in patients with severe chronic obstructive pulmonary disease [press release]LondonGSK2017 [May 10]. Available from: https://www.gsk.com/en-gb/media/press-releases/gsk-announces-headline-phase-iii-results-of-mepolizumab-in-patients-with-severe-chronic-obstructive-pulmonary-diseaseAccessed December 14, 2017
   Google Scholar
• PavordIDChanezPCrinerGJMepolizumab for eosinophilic chronic obstructive pulmonary diseaseN Engl J Med2017377171613162928893134
   PubMed Web of Science ®Google Scholar
• KeatingGMMepolizumab: First Global ApprovalDrugs201575182163216926603873
   PubMed Web of Science ®Google Scholar
• NUCALA [package insert]Research Triangle Park, NCGlaxo-SmithKline122017 Available from: https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Nucala/pdf/NUCALA-PI-PIL.pdfAccessed December 14, 2017
   Google Scholar
• BelEHWenzelSEThompsonPJOral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthmaN Engl J Med2014371131189119725199060
   PubMed Web of Science ®Google Scholar
• OrtegaHGLiuMCPavordIDMepolizumab treatment in patients with severe eosinophilic asthmaN Engl J Med2014371131198120725199059
   PubMed Web of Science ®Google Scholar
• PavordIDKornSHowarthPMepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trialLancet2012380984265165922901886
   PubMed Web of Science ®Google Scholar
• NairPDasguptaAKjarsgaardMMepolizumab in COPD with eosinophilic bronchitis: a randomized clinical trialJ Allergy Clin Immunol20161372AS392
   Web of Science ®Google Scholar
• CINQAIR^® [package insert]Frazer, PATeva Respiratory, LLC2016
   Google Scholar
• CastroMMathurSHargreaveFReslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled studyAm J Respir Crit Care Med2011184101125113221852542
   PubMed Web of Science ®Google Scholar
• CastroMZangrilliJWechslerMEReslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trialsLancet Respir Med20153535536625736990
   PubMed Web of Science ®Google Scholar
• FitzGeraldJMBleeckerERNairPBenralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trialLancet2016388100562128214127609406
   PubMed Web of Science ®Google Scholar
• BleeckerERFitzGeraldJMChanezPEfficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trialLancet2016388100562115212727609408
   PubMed Web of Science ®Google Scholar
• NairPWenzelSRabeKFOral glucocorticoid-sparing effect of benralizumab in severe asthmaN Engl J Med2017376252448245828530840
   PubMed Web of Science ®Google Scholar
• FajtMLWenzelSEAsthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized careJ Allergy Clin Immunol2015135229931125662302
   PubMed Web of Science ®Google Scholar
• PopeSMBrandtEBMishraAIL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanismJ Allergy Clin Immunol2001108459460111590387
   PubMed Web of Science ®Google Scholar
• CorrenJLemanskeRFHananiaNALebrikizumab treatment in adults with asthmaN Engl J Med2011365121088109821812663
   PubMed Web of Science ®Google Scholar
• HananiaNAKorenblatPChapmanKREfficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trialsLancet Respir Med201641078179627616196
   PubMed Web of Science ®Google Scholar
• BrightlingCEChanezPLeighREfficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2B trialLancet Respir Med20153969270126231288
   PubMed Web of Science ®Google Scholar
• WenzelSCastroMCorrenJDupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2B dose-ranging trialLancet201638810039314427130691
   PubMed Web of Science ®Google Scholar
• BarnesNPavordIChuchalinAA randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthmaClin Exp Allergy2012421384821762224
   PubMed Web of Science ®Google Scholar
• PettipherRHunterMGPerkinsCMHeightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459Allergy20146991223123224866478
   PubMed Web of Science ®Google Scholar
• SinghDCaddenPHunterMInhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459Eur Respir J2013411465222496329
   PubMed Web of Science ®Google Scholar
• StraumannAHoesliSBussmannCAnti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitisAllergy201368337538523379537
   PubMed Web of Science ®Google Scholar
• GonemSBerairRSingapuriAFevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trialLancet Respir Med20164969970727503237
   PubMed Web of Science ®Google Scholar
• McMaster UniversityMepolizumab in chronic obstructive pulmonary diseases (COPD) with eosinophilic bronchitis Available from: https://clinicaltrials.gov/ct2/show/NCT1463644. NLM identifier: NCT1463644Accessed December 14, 2017
   Google Scholar
• MedImmune LLCA study to evaluate the effectiveness of MEDI-563 in subjects with chronic obstructive pulmonary disease (COPD) Available from: https://clinicaltrials.gov/ct2/show/NCT1227278. NLM identifier: NCT1227278Accessed December 14, 2017
   Google Scholar